NCT00036127已完成2 期
Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 16
研究概览
简要总结
Study to learn if the alternate formulation is effective in agitated schizophrenic patients
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Agitated schizophrenic patients
排除标准
- 未提供
研究者
研究点 (16)
Loading locations...
相似试验
已完成
4 期
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietySchizophreniaSchizoaffective DisorderSocial Anxiety DisorderNCT00177008University of Medicine and Dentistry of New Jersey18
已完成
不适用
Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive functioschizophreniaJPRN-UMIN000002076Kyoto University Hospital20
已完成
4 期
Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic ProfileAntipsychotics Weight GainNCT02949752Institute of Mental Health, Singapore67
已完成
3 期
Aripiprazole Oral Acceptability TrialSchizophreniaNCT00101569Otsuka Pharmaceutical Development & Commercialization, Inc.59
已完成
不适用
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar DisorderSchizophreniaBipolar DisorderNCT00216723Korea Otsuka Pharmaceutical Co., Ltd.3,000